We are international
Donate
• health professionals TEXT SIZE   
   back

Dr. Zonder - Phase I Trial of HuLuc63 in Multiple Myeloma
Jeffrey A. Zonder, MD
Karmanos Cancer Institute
Detroit, Michigan
12.22.07


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles